Page 2 of Dr Lal Pathlabs

US Stocks, Wall Street, sectors, energy, travel, financials, U.S. presidential election, oil, dollar

Top stocks to buy post SEBI ruling: 5 high conviction midcap stocks with strong fundamentals, growth potential

The brokerage firm has prepared a basket of five high conviction midcap stocks which are fundamentally sound with good growth…

September 17, 2020 12:26 IST

Gayatri Projects’ JV wins contract worth Rs 1255 crore, shares surge 17 per cent

Dr Lal PathLabs shares gain today on expansion plans; up 80% since listing

Dr Lal PathLabs shares jumped over 2 per cent in the early trade on Friday on reports that the diagnostic…

Updated: June 10, 2016 16:05 IST

As Nifty ends below 8,900, these 65 stocks hit fresh 52-week high in Friday's trade

Muthoot Finance, Jubilant FoodWorks among 10 stocks that remained in focus in Monday’s trade

Muthoot Finance shares closed 8.72 per cent up at Rs 233.85 after the company reported 60.56 per cent rise in…

Updated: May 30, 2016 17:25 IST

Dr Lal PathLabs to acquire Delta Ria and Pathology

Diagnostic chain Dr Lal PathLabs today said it will fully acquire Delta Ria and Pathology while increasing its stake in…

May 27, 2016 20:48 IST

Dr Lal PathLabs Q4 net profit up 20 pct at Rs 34.44 crore

Diagnostic chain Dr Lal PathLabs today reported 19.79 per cent rise in consolidated net profit at Rs 34.44 crore for…

May 27, 2016 18:03 IST

Dr Lal, Alkem shares extend gains for second day after blockbuster listing

Share price of diagnostic chain Dr Lal PathLabs and drug major Alkem Laboratories surged 8.43 per cent and 10.16 per…

December 24, 2015 16:36 IST

Alone and loving it: Lal Pathlabs and five other stock singles

After the success of Dr Lal Pathlabs, we take a look at some companies which are the only listed ones…

Updated: December 23, 2015 16:20 IST

Dr Lal PathLabs surges 52%, Alkem Labs gains 31% on market debut

Alkem Laboratories shares opened 31.42 per cent up from its issue price of Rs 1,050 on BSE. Dr Lal Pathlabs…

Updated: December 23, 2015 17:01 IST

After Alkem and Dr Lal IPOs, Narayana Hrudayalaya set to hit market next week

Narayana Hrudayalaya is set to hit Dalal Street with its initial public offer (IPO) on December 17.

Updated: December 11, 2015 11:01 IST

IPOs of Dr Lal PathLabs, Alkem fully subscribed

Despite volatility in the secondary markets, initial public offerings (IPO) of Alkem Laboratories and Dr Lal PathLabs managed to get…

December 10, 2015 00:11 IST

Dr Lal PathLabs subscribed 0.65 times

The initial public offering (IPO) of Dr Lal PathLabs was subscribed 0.65 times on the first day of three day…

December 9, 2015 00:13 IST

Dr Lal PathLabs IPO hits market: Should you subscribe or avoid?

Dr Lal PathLabs’ price band for the offer has been fixed at Rs 540-550 per share and the allotment to…

Updated: December 9, 2015 09:11 IST

Dr Lal PathLabs mops up Rs 191 cr in pre-IPO placement

Dr Lal PathLabs plans to raise Rs 638 crore through the issue based on the upper price band

December 8, 2015 00:21 IST

Alkem Laboratories, Dr Lal Pathlabs IPOs hit markets; all you need to know

Dalal Street is set to witness two initial public offers (IPOs) this week from pharma and healthcare related companies -…

Updated: December 8, 2015 12:56 IST

Dr Lal PathLabs fixes IPO price band at Rs 540-550

Diagnostic chain Dr Lal PathLabs today fixed price band at Rs 540-550 for its initial public offer (IPO) which will…

December 1, 2015 09:26 IST

Dr Lal PathLabs gets Sebi nod for IPO

Kotak Mahindra Capital and Citigroup Global Markets India are the book running lead managers for the IPO.

November 10, 2015 09:59 IST

Dr Lal PathLabs plans IPO; files draft papers with Sebi

Diagnostic chain Dr Lal PathLabs is planning to go public and has filed draft papers with market regulator Sebi to…

Updated: September 15, 2015 14:02 IST

Dr Lal PathLabs announces expansion plans in Bengaluru city

Aims to open 50 centres and laboratories by December 2015 Dr Lal PathLabs is unveiling a series of initiatives designed…

September 3, 2015 17:59 IST

Related News

Aadhaar Card update October 2025: Here’s how to change name, address, date of birth and phone number online in simple steps

Yashasvi Jaiswal, test cricket, sachin tendulkar, Yashasvi Jaiswal test runs, Yashasvi Jaiswal test rankings, Yashasvi Jaiswal vs west indies, sports insights

After Sachin Tendulkar, India finally has a young test superstar

Who is Alexandr Wang? The 28-year-old hired by Mark Zuckerberg for $14 billion to head Meta’s Superintelligence Labs

Google manager quits Rs 3.4 crore job, says ‘the work was pleasant, but…’

'I'm in gold camp, not interested in...,' Zoho founder Sridhar Vembu explains why he prefers gold over crypto

Zoho’s Sridhar Vembu breaks language barriers, drops guide on how to say ‘Arattai’ in multiple languages

Retail IPO buzz fades as listing gains shrink

Market16 min ago

Retail investors’ involvement in IPOs has dropped, with lower subscription and listing gains. They typically focus on the listing pop and grey market. But the secondary market is rebounding, and long-term investment in IPOs is recommended. Traditional industries dominate the IPO market, while tech startups are a minority.

View all shorts

Photo Gallery

In Images | Delhi struggles with waterlogging as rains hit festival season plans

2 weeks agoSeptember 30, 2025

View All

Page 2 of Dr Lal Pathlabs

Related News

Photo Gallery

In Images | Delhi struggles with waterlogging as rains hit festival season plans

Trending Topics